Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

NCT01752985 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

319

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Diabetic Kidney Disease

Interventions

DRUG: BMS-813160
DRUG: Placebo matching with BMS-813160

Sponsor

Bristol-Myers Squibb